Table 1. Age and gender in both groups
| Variable | | Com. (n=100) | Mono. (n=100) | p |
| Freq. (%) | Freq. (%) |
| Gender | Male | 56 (56.0) | 45 (45.0) | 0.157* |
| Female | 44 (44.0) | 55 (55.0) |
| Age (year) | Median (quartile) | 39 (30.5 – 46) | 40.5 (32 – 47.5) | 0.646@ |
| Age-group | 18-19 | 3 (3.0) | 1 (1.0) | 0.660* |
| 20-29 | 21 (21.0) | 17 (17.0) |
| 30-39 | 27 (27.0) | 31 (31.0) |
| ≥40 | 49(49.0) | 51(51.0) |
| Liver enzymes (UI/L) | ALT | 110 (90 – 147) | 116 (90 – 147) | 0.767@ |
| AST | 79 (64 – 91) | 83 (73 – 98) | 0.072@ |
| GGT | 51 (34 – 76) | 45 (36 – 68) | 0.508@ |
| HBV DNA (copies/ml) | >105 – 106 | 20 (20.0) | 16 (16.0) | 0.167* |
| >106 – 107 | 32 (32.0) | 22 (22.0) |
| >107 – 108 | 17 (17.0) | 28 (28.0) |
| >108 – 109 | 31 (31.0) | 34 (34,0) |
| >105 – 106 | 20 (20.0) | 16 (16.0) |
Fisher’s exact test;
Mann-Whitney test; Com. combination therapy group; Mono. monotherapy group